Skip to main content

When essential isn’t good enough: new strategies for target-based drug discovery in M. tuberculosis and beyond

room FXB 301

Barbara Bosch MD, PhD Instructor in Clinical Investigation, The Rockefeller University "As a physician-scientist with academic training in clinical medicine and research experience in basic sciences, I strongly believe that translational research is needed to bridge the gap between scientific discovery and clinical medicine." THIS SPEAKER WILL BE IN PERSON IN FXB 301. The event...

Advancing LGBTQ health equity through epidemiology

Department of Epidemiology Seminar Series Speaker: Brittany Charlton, MSc, ScDAssociate Professor, Harvard Medical School, Harvard Pilgrim Health Care Institute, Harvard T.H. Chan School of Public Health Abstract: One in ten people in the U.S. are LGBTQ and this population will grow as that number is twice as high among young people. LGBTQ people experience widespread...

Quantitative Issues in Cancer Research Working Group Seminar

Building 2, Room 426

Omar Melikechi, Postdoctoral Research Fellow, Department of Biostatistics, Harvard University Integrated path stability selection Abstract: Feature selection aims to identify important features in a data set, which can lead to more accurate and interpretable results. For example, it has been used to identify genes that are associated with certain diseases. Stability selection is a popular...